Lv31
340 积分 2025-07-05 加入
Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells
45分钟前
已完结
A Prospective Phase II Trial of First-Line Osimertinib for Patients With EGFR Mutation-Positive NSCLC and Poor Performance Status (OPEN/TORG2040)
6天前
已完结
Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in Lung Cancer by Dendritic Cells
29天前
已完结
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma
29天前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
29天前
已完结
Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC
1个月前
已完结
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
1个月前
已完结
Treatment of Malignant Pleural Effusions
1个月前
已完结
Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy +/- chemotherapy in nonsquamous non-small cell lung cancer
1个月前
已完结
Effect of JAK/STAT Signaling on Anti-PD-L1 Immunotherapy Efficacy in Lung Cancer
1个月前
已完结
皖公网安备34019202002308
